DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?Jason A. Roberts, Juan Carlos Montejo, Sanjoy K. Paul et al.|Clinical Infectious Diseases|2014Cited by 1.1k
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe SepsisSteven M. Opal, for the ACCESS Study Group, Marc Van Nuffelen et al.|JAMA|2013Cited by 797
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shockFabio Silvio Taccone, Frédérique Jacobs, Pierre‐François Laterre et al.|Critical Care|2010Cited by 372
Compartmentalization of the Inflammatory Response during Acute PancreatitisThierry Dugernier, Jérôme Pugin, Pierre‐François Laterre et al.|American Journal of Respiratory and Critical Care Medicine|2003Cited by 229
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shockFabio Silvio Taccone, Frédérique Jacobs, Pierre‐François Laterre et al.|Critical Care|2010Cited by 199